Cancer, Inflammation and Immunity - Harnessing the Body’s Defenses to Fight Cancer
Type
Blog Post
Published
July 6, 2017, 1:59 p.m.
...in immunotherapy is the combination of the CRISPR/Cas9 methodology with T cell receptor engineering (Ref...using randomly integrating viral vectors, CRISPR/Cas9 genome editing allows targeted engineering of the.... "Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection." Nature 543.7643 (2017...